Phase 3 Ankylosing Spondylitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are able to understand what the trial involves and are willing to follow the study rules and sign a consent form
- You are at least 18 years old (any gender can apply)
- You have been diagnosed with ankylosing spondylitis (a type of inflammatory arthritis affecting the spine) based on a specific set of recognised medical criteria
- You have tried common anti-inflammatory pain medications (such as ibuprofen or naproxen) but they have not worked well enough for you, or you are unable to take them due to side effects or other health reasons
- You are willing to use contraception and have no plans to become pregnant, donate sperm, or donate eggs from the start of the study until at least 6 months after your last dose of the study treatment
Who may not be able to join:
- You have other inflammatory diseases that are currently active and not well controlled
- Your blood tests or other medical tests show results that are considered significantly abnormal (confirm with trial site)
- You currently have an active Hepatitis B, Hepatitis C, or HIV infection, confirmed by a blood test at the start of the study
- You have a history of cancer
- You have a known or suspected history of a weakened immune system
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 18911301578
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The Percentage of Participants Who Achieved an Assessment of Spondylo Arthritis International Society (ASAS) 40 Response.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.